| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9652 |
| Human Intestinal Absorption | HIA+ | 0.9807 |
| Caco-2 Permeability | Caco2+ | 0.7301 |
| P-glycoprotein Substrate | Substrate | 0.5676 |
| P-glycoprotein Inhibitor | Inhibitor | 0.5484 |
| Non-inhibitor | 0.7155 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8048 |
| Distribution |
| Subcellular localization | Mitochondria | 0.9371 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7837 |
| CYP450 2D6 Substrate | Non-substrate | 0.8985 |
| CYP450 3A4 Substrate | Substrate | 0.6426 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8499 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.6419 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9193 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8132 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.7807 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9204 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9507 |
| Non-inhibitor | 0.6514 |
| AMES Toxicity | Non AMES toxic | 0.9614 |
| Carcinogens | Non-carcinogens | 0.8711 |
| Fish Toxicity | High FHMT | 0.9887 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9760 |
| Honey Bee Toxicity | High HBT | 0.6484 |
| Biodegradation | Not ready biodegradable | 0.7952 |
| Acute Oral Toxicity | III | 0.6112 |
| Carcinogenicity (Three-class) | Non-required | 0.6225 |